Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matej Horvat

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
BMC Cancer|July 2, 2025
Scoping review: (Bio)markers for the prognostication of breast cancer recurrenceRigon Sallauka, Matej Horvat, Maja Ravnik, et al.
Radiology and Oncology|July 26, 2017
Single Nucleotide Polymorphisms in Genes <i>MACC1, RAD18, MMP7</i> and <i>SDF-1a</i> As Prognostic Factors in Resectable Colorectal CancerMatej Horvat, Uros Potocnik, Katja Repnik, et al.
Bioanalysis|November 30, 2023
Signal-to-noise ratio to assess magnitude, kinetics and impact on pharmacokinetics of the immune response to an adalimumab biosimilarDavide Guerrieri, Matej Horvat, Jamie Fan, et al.
International Journal of Cardiology|November 19, 2015
Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure: A randomized, double-blind, controlled trialTina Roblek, Andreja Deticek, Bostjan Leskovar, et al.
Oncology Letters|February 23, 2018
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisoloneMatej Horvat, Vesna Zadnik, Tanja Južnič Šetina, et al.
Drug Development and Industrial Pharmacy|April 3, 2020
Step-wise approach to developing a scale-independent design space for functional tablet coating processVeronika Debevec, Tijana Stanić Ljubin, Žiga Jeraj, et al.
International Journal of Pharmaceutics|June 11, 2019
Elucidating molecular properties of kappa-carrageenan as critical material attributes contributing to drug dissolution from pellets with a multivariate approachSara Vidovič, Matej Horvat, Alan Bizjak, et al.
Expert Opinion on Biological Therapy|November 15, 2024
Comparing anti-drug antibody signal-to-noise ratios to assess immunogenicity and interchangeability in adalimumab biosimilar studiesLena Lemke, Andrew Blauvelt, Ines Brückmann, et al.
Sensors (Basel, Switzerland)|February 24, 2024
Multilingual Framework for Risk Assessment and Symptom Tracking (MRAST)Valentino Šafran, Simon Lin, Jama Nateqi, et al.
Sexuality Research & Social Policy : Journal of NSRC : SR & SP|October 5, 2021
"I Don't Even Want to Come Out": the Suppressed Voices of Our Future and Opening the Lid on Sexual and Gender Minority Youth Workplace Discrimination in Europe: a Qualitative StudyRadhika Seiler-Ramadas, Lovro Markovic, Chase Staras, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
BMC Cancer|July 2, 2025
Scoping review: (Bio)markers for the prognostication of breast cancer recurrenceRigon Sallauka, Matej Horvat, Maja Ravnik, et al.
Radiology and Oncology|July 26, 2017
Single Nucleotide Polymorphisms in Genes <i>MACC1, RAD18, MMP7</i> and <i>SDF-1a</i> As Prognostic Factors in Resectable Colorectal CancerMatej Horvat, Uros Potocnik, Katja Repnik, et al.
Bioanalysis|November 30, 2023
Signal-to-noise ratio to assess magnitude, kinetics and impact on pharmacokinetics of the immune response to an adalimumab biosimilarDavide Guerrieri, Matej Horvat, Jamie Fan, et al.
International Journal of Cardiology|November 19, 2015
Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure: A randomized, double-blind, controlled trialTina Roblek, Andreja Deticek, Bostjan Leskovar, et al.
Oncology Letters|February 23, 2018
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisoloneMatej Horvat, Vesna Zadnik, Tanja Južnič Šetina, et al.
Drug Development and Industrial Pharmacy|April 3, 2020
Step-wise approach to developing a scale-independent design space for functional tablet coating processVeronika Debevec, Tijana Stanić Ljubin, Žiga Jeraj, et al.
International Journal of Pharmaceutics|June 11, 2019
Elucidating molecular properties of kappa-carrageenan as critical material attributes contributing to drug dissolution from pellets with a multivariate approachSara Vidovič, Matej Horvat, Alan Bizjak, et al.
Expert Opinion on Biological Therapy|November 15, 2024
Comparing anti-drug antibody signal-to-noise ratios to assess immunogenicity and interchangeability in adalimumab biosimilar studiesLena Lemke, Andrew Blauvelt, Ines Brückmann, et al.
Sensors (Basel, Switzerland)|February 24, 2024
Multilingual Framework for Risk Assessment and Symptom Tracking (MRAST)Valentino Šafran, Simon Lin, Jama Nateqi, et al.
Sexuality Research & Social Policy : Journal of NSRC : SR & SP|October 5, 2021
"I Don't Even Want to Come Out": the Suppressed Voices of Our Future and Opening the Lid on Sexual and Gender Minority Youth Workplace Discrimination in Europe: a Qualitative StudyRadhika Seiler-Ramadas, Lovro Markovic, Chase Staras, et al.
Pageof 3